Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.00-1.02%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.50% | 35.58% | 4.21% | -72.86% | 26.28% |
| Total Depreciation and Amortization | 26.09% | -26.92% | -27.59% | -31.25% | -41.03% |
| Total Amortization of Deferred Charges | -67.06% | -80.05% | -87.38% | -72.43% | -42.78% |
| Total Other Non-Cash Items | 78.19% | -95.43% | -205.52% | -133.96% | -212.93% |
| Change in Net Operating Assets | 132.87% | 21.34% | 12.37% | 260.49% | 3,146.67% |
| Cash from Operations | -17.83% | -27.04% | -2,923.94% | -52.10% | -84.80% |
| Capital Expenditure | 41.67% | 53.85% | 46.67% | 29.41% | 36.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.40% | 2.99% | 274.33% | 704.34% | 270.73% |
| Cash from Investing | -13.10% | 3.53% | 282.29% | 678.70% | 267.74% |
| Total Debt Issued | 4.33% | -43.11% | -54.80% | -58.80% | -38.65% |
| Total Debt Repaid | -5.02% | 36.81% | 49.81% | 27.15% | -8.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.17% | -200.43% | -20.03% | -154.62% | -143.85% |
| Foreign Exchange rate Adjustments | -60.00% | 222.22% | 125.93% | -18.75% | -58.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -284.80% | -490.24% | -511.29% | -320.15% | -176.69% |